Posted: March 13, 2013 at 4:46 pm
Dr Alok Sharma Stem Cell Therapy for Duchenne Muscular Dystrophy in Gujarati
Dr Alok Sharma Stem Cell Therapy for Duchenne Muscular Dystrophy in Gujarati 16 years old male with history of frequent falls and being slow as compared to p...
By: neurogenbsi
Excerpt from:
Dr Alok Sharma Stem Cell Therapy for Duchenne Muscular Dystrophy in Gujarati - Video
Posted: March 13, 2013 at 4:46 pm
Dr Alok Sharma Stem Cell Therapy Treatment for Cerebral Palsy
Dr Alok Sharma Stem Cell Therapy Treatment for Cerebral Palsy He is a known case of Diplegic CP with history of full term normal delivery (vaccum) delivery a...
By: neurogenbsi
Read the rest here:
Dr Alok Sharma Stem Cell Therapy Treatment for Cerebral Palsy - Video
Posted: March 13, 2013 at 4:46 pm
Prolotherapy | PRP | Stem Cell Therapy | The Prolotherapy Institute - prolotherapyinstitute.com
Prolotherapy | PRP | Stem Cell Therapy | The Prolotherapy Institute prolotherapyinstitutecom. Uploaded by Guillermo Mata on Mar 11 2013. Suffering from chronic pain Dr Darrow can help Prolotherapy | PRP | Stem Cell Therapy in Southern California Call The Prolotherapy Institute today Call Us Today to Make an Appointment800 7342210.
By: Guillermo Mata
Continued here:
Prolotherapy | PRP | Stem Cell Therapy | The Prolotherapy Institute - prolotherapyinstitute.com - Video
Posted: March 12, 2013 at 1:47 am
Newswise LOS ANGELES (March 10, 2013) Cedars-Sinai Medical Center will commemorate Brain Awareness Week, March 11-17, with educational programs featuring robotic technology that enables doctors to check on their patients from home, stem cell research that may revolutionize many medical therapies, and some of the top experts in nanotechnology including Roger Tsien, PhD, who received the 2008 Nobel Prize in Chemistry.
Brainworks, 10 a.m. to 1:10 p.m., March 11, Harvey Morse Auditorium
A robotic assistant will be a special guest at the Brainworks program for 130 seventh- and eighth-graders. Dependable, focused and able to perform tasks at any time, 24 hours a day, Robot-Doc has become a key member of the Neuroscience Critical Care Unit.
The InTouch Health RP-7i robot enables several doctors to teleconference, bringing them together by remote presence to collaborate in the Critical Care Unit. Students attending Brainworks part of Cedars-Sinais commemoration of Brain Awareness Week March 11 to 17 will be able to drive and interact with the RP-7i and learn more about these devices from neurointensive care experts and a representative of InTouch Health.
Brainworks came about because we wanted to expose as many young minds as possible to how exciting science is and especially how fascinating the brain is, said Keith L. Black, MD, professor and chair of the Department of Neurosurgery, who started the program in 1998.
Patrick D. Lyden, MD, chair of the Department of Neurology, will be the keynote speaker. Lyden, director of the Stroke Program and the Carmen and Louis Warschaw Chair in Neurology, is widely known for his leadership in stroke research and treatment.
Brainworks attendees will get hands-on experience as they visit interactive areas such as: a virtual surgery station with 3-D imaging and microscope with phantom skull; a surgical instrumentation station with tools used in the operating room; a neuropathology station with real sheep brains and microscope slides of various tumor types; a rehabilitation and healing station where students learn what its like to apply and receive therapy; a suture station that gives students the chance to mend wounds; a brain and spine instrumentation station showing some of the hardware used in treatment; and a research station where students can see and participate in DNA, tumor and laser experiments.
Introduction to the World of Stem Cells, 5 to 7 p.m., March 14, Harvey Morse Auditorium
As many as 130 high school students, parents and teachers will learn from research scientists and clinicians the basics of stem cells, which may revolutionize many medical therapies in coming years. Sessions will include: An introduction to stem cells and issues related to different types; differing scientific opinions, ethical issues and how scientists are working to resolve conflicts; adult stem cells versus embryonic stem cells for therapy; careers related to stem cells; and a stem cell Jeopardy! game.
The program will be led by John S. Yu, MD, vice chair of the Department of Neurosurgery and director of surgical neuro-oncology, and Dwain Morris-Irvin, PhD, neural stem cell research scientist and principal investigator with the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai. Ahmed Ibrahim, who has a masters degree in public health and is in Cedars-Sinais Graduate Program in Biomedical Science and Translational Medicine, also will speak. As a high school student, Ibrahim participated in a summer research project at Cedars-Sinai. He now conducts stem cell research at the Cedars-Sinai Heart Institute.
See the article here:
Robotic Assistants, Stem Cells , Nanotechnology: Cedars-Sinai Programs for Students and Professionals During Brain ...
Posted: March 12, 2013 at 1:46 am
NEW YORK, NY--(Marketwire - Mar 11, 2013) - TriMarkPublications.com cites in its newly published "Regenerative Medicine Markets" report that the regenerative medicine market will catapult to over $35 billion by 2019. For more information, visit: http://www.trimarkpublications.com/regenerative-medicine-markets/.
Regenerative medicine (RM) can be categorized into three main modalities: tissue engineering, biomaterials and biomolecules, e.g., scaffolds, growth factors and stem cell therapy. Tissue-engineered bone products in the orthopedic segment will see steady growth, from $7.5 billion in 2012 to $3.29 billion in 2019. The up-and-coming cardiology and vascular products segment will also see substantial growth, reaching a market value of $3.29 over the forecast period.
The "Regenerative Medicine Markets" report covers:
The "Regenerative Medicine Markets" report examines companies manufacturing regenerative medicine equipment and supplies in the world. Companies covered include: Amorcyte, Ars Arthro, Axiogenesis, AxoGen, Bellicum, BetaStem, Bioheart, Biomet, BioMimetic, BioTissue, Biovest, BrainStorm Cell, California Stem Cell, Cardio3, Cellartis, CellSeed, Cellular, Chromocell, Cognate, Cook, Cytomedix, Cytonet, Cytori, DanDrit, Fibrocell, Forticell, Gamida, Harvest, Histogenics, Humacyte, Integra, Intercytex, iPierian, Japan Tissue Engineering, Kensey Nash, Kiadis, Life Cell, Living Cell, MaxCyte, MediStem, Mesoblast, MolMed, NanoCor, Neuralstem, NeuroNova, NewLink Genetics, Olympus Terumo, OncoMed, Opexa, Organogenesis, Orthovita, Osiris, Osteotech, Pervasis, Pluristem, Proneuronnologies, RegeneRx, ReNeuron, Revivicor, SanBio, Saneron, Sangamo, Stem Cell Authority, StemCells, Stemline, Stratetech, Synthecon, Tengion, Thermogenesis, TiGenics, Tissue Genesis, ViaCyte, Vistagen and Zen-Bio.
Detailed charts with sales forecasts and marketshare data are included. For more information, visit: http://www.trimarkpublications.com/regenerative-medicine-markets/.
About TriMarkPublications.com
TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit http://www.trimarkpublications.com.
Important Notice
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.
See more here:
Regenerative Medicine Market to Catapult to Over $35 Billion by 2019
Posted: March 12, 2013 at 1:45 am
By Roger Dobson
PUBLISHED: 22:48 EST, 11 March 2013 | UPDATED: 23:38 EST, 11 March 2013
Sitting in a diving chamber may be a new treatment for type 2 diabetes, the most common form of the condition.
Scientists are combining the treatment with injections of a patients own stem cells in a bid to kick-start insulin production.
They believe the high levels of oxygen in the chamber boosts the activity of the stem cells, helping them to repair the cells in the body that produce insulin.
There are around 2.9 million Britons with diabetes, with most of them suffering from type 2
In a new trial, patients with type 2 diabetes reduced their need for insulin and metformin (a common diabetes drug) with some no longer needing the insulin at all.
So-called hyperbaric oxygen therapy involves a patient sitting in a pressurised chamber.
The high-pressure atmosphere means they breathe in three times as much oxygen as they would normally.
The treatment is normally used for helping divers who have surfaced too quickly and have the bends (where bubbles of nitrogen form in the blood).
The rest is here:
Diabetes : Deep-sea diving tank combined with stem cells to treat condition
Posted: March 12, 2013 at 1:44 am
LONDON (SHARECAST) - ReNeuron Group has won two grants worth 1.2m pounds to develop its stem cell therapy.
The grants were awarded by the UK Biomedical Catalyst, a programme of public funding jointly managed by the Technology Strategy Board and the Medical Research Council.
The first award of 0.4m will be used for ReNeurons ReN009 stem cell therapy candidate for critical limb ischaemia, a severe blockage in the arteries which markedly reduces blood-flow to the extremities including hands, feet and legs.
The second award of 0.8m relates to the company's ReN003 stem cell candidate for the treatment of retinitis pigmentosa, an eye disease in which there is damage to the retina.
Michael Hunt, the Chief Executive Officer of ReNeuron, said: "We are delighted to have been successful in winning the two grants we applied for in the current round of the Biomedical Catalyst funding competition.
"This highly competitive scheme involves a rigorous peer review of applicants' technologies and commercial development plans.
"In common with other awardees, we therefore regard the grants as representing a strong independent endorsement of ReNeuron's world-class stem cell development capabilities which we hope will eventually lead to the wide-scale treatment of disease conditions where there is currently a very large unmet medical need."
Shares rose 0.86% to 2.94p at 08:52 Monday.
RD
Go here to see the original:
ReNeuron Group wins grants for stem cell therapy development
Posted: March 12, 2013 at 1:44 am
With its growing popularity in the country, the so-called stem cell therapy, which was recently approved by the Department of Health (DOH), is now available in Davao City.
Dr. Luz Acosta, a Davao-born physician specializing in Ophthalmology, Oculoplastic Reconstructive Surgery, Cosmetic Surgery and recently Stem Cell Treatment, conducts the procedure after acquiring equipment from Australia and the USA. She is supported by a team that includes cardiologists, internists, and anesthesiologists who administer the laboratory tests and cardiopulmonary clearance to determine if an individual can safely undergo stem cell therapy. Having trained in this discipline abroad, she recently decided to offer this treatment after it was approved by the DoH.
As a founding member of the Philippine Society for Stem Cell Medicine that was only established last January 18, 2013 with DOH Sec. Dr. Enrique Ona as its honorary chair, Acosta is joined by doctors Jose Sabili, Melchor Santos, Christian Mancao, Leo Olarte, Bu Castro, Oscar Tinio, and Almond Derla as well as Mr. Rico Colayco as organizers of the society.
"This means that the Philippine Society for Stem Cell Medicine is the regulating body for the practice of stem cell treatment in the country," Acosta says. "Stem cell therapy is legal and safe for every medically cleared patient who wants to undergo such treatment to be rejuvenated and treated of his/her illnesses and diseases."
Acosta said that based on what was stipulated in the approved directions for stem cell therapy, the stem cell could just come from the person himself and not from the other sources like black sheep or aborted fetus, adding that sources of stem cells are fats, blood, bone marrow and umbilical cord.
"It could take five to six hours for one to undergo stem cell therapy. Harvesting is done in the first two hours, then another one to two hours for stem cell processing and activation, and the last one to two hours for treatment of stem cells back to the same patient," she said.
Popular personalities who have already publicly admitted that they had undergone stem cell therapy are former President Joseph Estrada, Senate President Juan Ponce Enrile and former Senator Ernesto Maceda, who said that they spent millions to pay for the treatment.
But Acosta said that it could be a lot cheaper here than abroad, as the cost of treatment will be in accordance to the guidelines of the Phil. Society for Stem Cell Medicine.
She said there have been very good clinical outcomes from stem cell treatments on autism, auto-immune diseases, cerebral palsy, diabetes, heart disease, liver cirrhosis, macular degeneration, multiple sclerosis, nerve damage, osteoarthritis, spinal cord injury and stroke.
"But we have to clarify here that we are not claiming stem cell therapy as a cure for cancer, though it can alleviate pain and improve patients' wellbeing while undergoing cancer therapy," she said.
Read more:
Stem Cell Therapy Now In Davao
Posted: March 11, 2013 at 10:48 am
Luigi Naldini - Modified stem cells for therapeutics applications
Luigi Naldini - San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Italy Dr Luigi Naldini talks at the IFOM-Kyoto University Joint Symposium in Mi...
By: IFOMeu
See the original post here:
Luigi Naldini - Modified stem cells for therapeutics applications - Video
Posted: March 11, 2013 at 10:48 am
Bone Marrow Transplant Patient Information: Chapter 3 - What Are Stem Cells
Transplantation of bone marrow or stem cells offers hope and a chance for a cure for many patients. For patients diagnosed with lymphoma, multiple myeloma, a...
By: HenryFordTV
Read the original:
Bone Marrow Transplant Patient Information: Chapter 3 - What Are Stem Cells - Video
